AI-generated summary
The authors studied photobiomodulation (808 nm light) in rats with photothrombotic stroke and in cultured neurons and cells exposed to oxygen-glucose deprivation. They report that treatment increased synaptic proteins and a neuroprotective astrocyte marker while reducing a neurotoxic astrocyte marker, and improved cell viability in culture. Limitations include the small-scale in vitro and in vivo models.
- Who or what was studied
- Rats with photothrombotic ischemic stroke (in vivo), and primary cortical neurons, N2a cells and astrocytes (in vitro)
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract reports only laboratory and animal models, with no human participants and no stated sample sizes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Stroke, Nitric oxide, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.